Axial Biotherapeutics

About:

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

Website: http://axialtx.com

Twitter/X: axialbiotx

Top Investors: Seventure Partners, UTokyo Innovation Platform, Longwood Fund, Corundum Systems Biology, Taiho Ventures

Description:

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)axialbiotherapeutics.com

Founders:

David Donabedian, PhD

Number of Employees:

11-50

Last Funding Date:

2021-10-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai